 | ||||||||
| health | ||||||||
| NEWS | ||||||||
Congress reshapes Medicare payments with bipartisan bill WASHINGTON - Conservatives hated that it's expected to swell federal deficits over the coming decade. Liberals complained that it shortchanged health programs for children and women.
| ||||||||
Health Highlights: April 15, 2015 A bill that changes the way Medicare pays doctors was passed by the Senate in a 92-8 vote Tuesday and now goes to President Barack Obama for final approval.
| ||||||||
Health Highlights: April 15, 2015 The word "healthy" should be removed from the labels of four types of Kind granola bars because they contain higher levels of saturated fat than is acceptable under regulatory standards for the term, the U.S.
| ||||||||
Snoring, apnea linked to earlier memory decline in eldery Older people who have sleep apnea, which can be marked by heavy snoring, tend to begin experiencing cognitive decline about 10 years earlier than those without the disorder or those who use a breathing machine to treat their apnea, according to a new ...
| ||||||||
Approved Pfizer breast cancer drug impresses in latest study (Reuters) - Pfizer Inc said on Wednesday the first formal late-stage trial of its approved treatment for advanced breast cancer, Ibrance, was stopped early after the medicine met its goal of delaying progression of the disease in previously treated patients.
| ||||||||
FDA Approves Amgen Heart Failure Drug The FDA on Wednesday approved ivabradine (Corlanor), Amgen's new heart failure drug. The drug has been available for several years in Europe, where it is sold by Servier under the brand names of Corlentor and Procoralan.
| ||||||||
FDA approves Amgen heart failure drug Corlanor Biotech company Amgen Inc. took a key step in its expansion into cardiovascular drugs Wednesday when the Food and Drug Administration approved its heart failure drug for sale in the United States.
| ||||||||
Pfizer Breast Cancer Drug Ibrance Demonstrates Impressive Results Pfizer announced that Ibrance, its treatment for advanced cancer demonstrated impressive results during the late-stage trial, which was stopped early because of its efficacy.
| ||||||||
FDA Approves New Type Of Heart Failure Drug TRENTON, N.J. (AP) - Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S.
| ||||||||
FDA approves new type of heart failure drug from Amgen TRENTON, N.J.. Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S.
| ||||||||
Approved Pfizer breast cancer drug impresses in latest study Pfizer Inc said on Wednesday the first formal late-stage trial of its approved treatment for advanced breast cancer, Ibrance, was stopped early after the medicine met its goal of delaying progression of the disease in previously treated patients.
| ||||||||
Pfizer Breast Cancer Drug Exhibit Impressive Results The drug against breast cancer Pfizer, Ibrance clinical trial has been delayed due to inefficiencies on the basis of the assessment of the independent Data Monitoring Committee (DMC), but after the problems have been solved from clinical trial was continued.
| ||||||||
After snowy winter, experts warn of boom in tick population — and not just in the ... HARSH winters, like the one that recently ended, have a chilling side effect: more ticks than usual. Heavy snow acts as insulation, protecting the Lyme disease-carrying creepers from the cold, leading to a spike in tick populations in the Northeast, experts warn ...
| ||||||||
Pfizer's Breast Cancer Drug Succeeds in Having Preliminary Approval Pfizer's Ibrance breast cancer drug was moving on to its late stage clinical trial when due to efficacy problems the progress ceased.
| ||||||||
Pfizer Breast Cancer Drug Gets Preliminary Approval Pfizer's Ibrance breast cancer drug was just in a late stage clinical trial when efficacy issues ceased any further progress. Fortunately, Pfizer managed to get everything back on track.
| ||||||||
Pfizer's breast cancer drug is promising, clinical trial shows 21 Ibrance, Pfizer's breast cancer drug was on its late clinical trial stage when halted due to efficacy issues. When the issue was set, Pfizer continued its clinical trial and the result seems to be good.
| ||||||||
Pfizer Breast Cancer Drug Shows Promising Results The clinical trial of Pfizer's breast cancer was stopped due to efficiency issue. However, the firm resumed the clinical trial after the issues were resolved.
| ||||||||
Pfizer breast cancer drug receives preliminary approval Pfizer Inc has halted its late stage 3 trials (PALOMA-3 trial) of ibrance breast cancer drug in combination with fulvestrant after being fortunate to get everything back on track.
| ||||||||
The Scary Consequence of Snoring If you don't snore, you likely know someone who does. Between 19% and 40% of adults snore when they sleep, and that percentage climbs even higher, particularly for men, as we age.
| ||||||||
Pfizer's breast cancer drug meets primary endpoint breast cancer drug The clinical trial of the Pfizer's breast cancer drug was halted due to some problems relating to the performance of the drug, but now the problems have been solved and now the drug is ready for clinical trial.
| ||||||||
Pfizer Breast Cancer drug shows promise Problems with the clinical trial of Pfizer's Breast Cancer drug were resolved and it is showing improvement in progression-free survival.
| ||||||||
US FDA approves Amgen's Corlanor heart failure drug (Reuters) - U.S. health regulators on Wednesday approved Amgen Inc's Corlanor to treat patients with chronic heart failure, giving the world's largest biotechnology company its first cardiovascular product.
| ||||||||
Cognitive aging, ways to slow it "The brain ages in all of us, but there's wide variability in the way the brain ages," says committee chair Dan Blazer, an emeritus professor of psychiatry at Duke University Medical Center in Durham, N.C.
| ||||||||
Pfizer Ibrance Breast Cancer Drug Shows Promising Results During Clinical Trial Pfizer's breast cancer drug Ibrance shows encouraging results in clinical trials. The drug is far more effective in delaying breast cancer progression in comparison to other drugs.
| ||||||||
Mississippi Law Could Expand Services for People with Autism #JACKSON, Miss. (AP) - Brian and Laura Beth Johnston of Madison learned in December that their 4-year-old son, Fraiser, has autism.
| ||||||||
Advisory issued on Lyme disease and outdoor ticks in Onondaga County After many cases of Lyme disease this year, the Onondaga County Health Department has warned residents in Syracuse, New York, and the surrounding areas to be aware of ticks when they go outdoors and to take all possible precautions against coming in ...
| ||||||||
California officials may declare end of Disneyland-linked measles outbreak (Reuters) - A measles outbreak in California that has been traced to Disneyland in December and renewed a debate over the anti-vaccination movement would be declared over on Friday if no new related cases arise, a public health official said on Thursday.
| ||||||||
FDA: Some KIND bars not as healthy as they claim Some popular snack bars will be getting a label makeover after the FDA accused the manufacturer of making false health claims. A warning letter posted by the Food and Drug Administration said four varieties of KIND bars do not meet the standards for ...
| ||||||||
Onondaga County Residents receive warning on Lyme disease The Onondaga County Health Department has said that they have already seen cases of Lyme disease this year, due to which they have been reminding the residents to take precautions before heading outside.
| ||||||||
Powassan virus appears to be returning to New Jersey after the death of a resident Powassan virus A 52-year-old Warren County woman died two years ago in May 2013 in what health officials later ascribed to Powassan virus, a tick-borne virus that is transmitted by Ixodes cookei or groundhog ticks, and Ixodes scapularis or deer ticks.
| ||||||||
Fatal Tick-Borne Virus Could be a New Jersey Nightmare This Spring Experts have expressed concern over a deadly tick-borne virus already known to have caused human deaths, which may now be on the loose in New Jersey.
| ||||||||
New Jersey Alerted Of Tick-Borne Virus This Spring This is the time to enjoy outdoors as weather is finally thawing. However, it is true the ticks probably love the spring more than us.
| ||||||||
List of diseases spread by deer tick grows, including malaria-like problems and ... Press Release: Burness Communications, November 12, 2012. An emerging tick-borne disease that causes symptoms similar to malaria is expanding its range in areas of the northeast where it has become well-established, according to new research ...
| ||||||||
Deadly tick-borne virus is on New Jersey's radar The Powassan virus has gained the attention of health officials in New Jersey. It's rarer than Lyme disease, but this tick-borne illness is deadlier and has had some activity in the Garden State over the past couple years.
| ||||||||
Study: Acetaminophen reduces not only pain, but pleasure, too (CNN) Feeling so happy you just can't stand it? You might want to pop some acetaminophen. A new study has found that acetaminophen, the main ingredient in Tylenol, most forms of Midol and more than 600 other medicines, reduces not only pain but ...
| ||||||||
Some Doctors Still Dismiss Parents' Concerns About Autism Some doctors aren't up to date on how to assess autism symptoms in very young children. iStockphoto. Most children with autism get diagnosed around age 5, when they start school.
| ||||||||
Study Examines Complications of Opioid Use During Pregnancy Opioid drugs are a big problem in the United States. But while it may be very easy to point the finger at addicts and those who abuse the drug, opioid painkillers—the prescription kind—do make a valid contribution to people with chronic pain.
| ||||||||
Glass Scare Spurs Beech-Nut Baby Food Recall April 15, 2015 -- About 1,920 pounds of baby food have been recalled by Beech-Nut Nutrition because products may contain small pieces of glass, the U.S.
| ||||||||
Use Of Opioids During Pregnancy Put Babies At Risk of Neonatal Abstinence ... As indicated by analysts, pregnant women who have been on prescription Opioids amid pregnancy stand a higher risk of presenting their children to the 'neonatal abstinence syndrome'.
| ||||||||
Opioids use During Pregnancy Harmful for Your Baby Analysts indicate that pregnant women who have been taking prescription Opioids are at higher risk of presenting their children to the neonatal abstinence syndrome that is a drug withdrawal syndrome linked to use of unlawful drugs during pregnancy.
| ||||||||
Autism Risk Could be Predicted by Parental Sperm The findings of a new study have revealed that the father's sperm could hold clues about whether the child will be at an increased risk of autism.
| ||||||||
Beech-Nut recalls sweet potato and chicken baby food The recalled baby food is packaged in four-ounce glass jars and labeled "Stage 2 Beech-Nut Classics Sweet Potato & Chicken." (Photo: Beech-Nut Nutrition).
| ||||||||
Possible cause of Alzheimer's found Scientists have broken new ground in the search for an Alzheimer's cure, discovering a new potential cause of the disease, which, it may be possible to target with drug treatments.
| ||||||||
Heavy Snoring, Apnea Tied to Earlier Brain Troubles (HealthDay News) -- Heavy snorers and people with sleep apnea may be more likely to develop memory and thinking problems at younger ages than their well-rested peers, a new study suggests.
| ||||||||
Divorce induces heart attacks, women are worst affected Women who have been divorced once, or men who have been divorced at least twice, are more likely to have a heart attack than people who get and stay married, according to a new study.
| ||||||||
Pfizer Breast-Cancer Drug Study Meets Primary Endpoint Pfizer Inc. PFE 1.03 % on Wednesday said a late-stage study of its Ibrance breast-cancer drug in combination with fulvestrant was stopped early after meeting its primary endpoint of demonstrating improvement in progression-free survival.
| ||||||||
Governor Deal signs medical marijuana bill Georgia Governor Nathan Deal signed HB1, legislation that permits the use of medical cannabis oil to treat certain conditions, Thursday morning.
| ||||||||
'Specialty drugs' hit patients, state in the wallet A practice by health insurers to shift more drugs into high-cost "specialty" categories is pushing those treatments out of the reach of California patients with chronic and life-threatening diseases and caught the attention the state's policymakers who are looking ...
| ||||||||
Divorcees more likely to get heart attacks Divorcees are more likely to have a heart attack than their peers who stay married, US research suggests. Ads by Google. Share. Facebook · Twitter · Google · Email.
| ||||||||
Divorce tied to increased heart attack risk (Reuters Health) - Women who have been divorced once, or men who have been divorced at least twice, are more likely to have a heart attack than people who get and stay married, according to a new study.
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment